Charlotte's Web Welcomes New CMS Guidance on Hemp Products

The company applauds the Centers for Medicare & Medicaid Services for expanding access to eligible full-spectrum hemp products.

Mar. 21, 2026 at 4:33am

Got story updates? Submit your updates here. ›

Charlotte's Web Holdings, Inc., a leading botanical wellness company, has expressed gratitude to the Centers for Medicare & Medicaid Services (CMS) for its new guidance that advances structured access to eligible full-spectrum hemp products through current CMS Innovation Center models. The CMS's Substance Access Beneficiary Engagement Incentive (BEI) program defines eligible hemp products to include orally administered products containing up to 3 mg per serving of tetrahydrocannabinols, accommodating non-intoxicating full-spectrum hemp-derived CBD products.

Why it matters

This forward-looking framework from CMS supports patient-provider discussions around eligible hemp products, reinforcing science-driven policymaking that prioritizes consumer safety and product quality. It aligns with Charlotte's Web's mission to advance safe, high-quality, science-backed hemp options for consumers and the company's commitment to supporting sensible legislation that protects patients and strengthens the integrity of the hemp industry.

The details

Under the BEI program, CMS has defined eligible hemp products to include orally administered products containing up to 3 mg per serving of tetrahydrocannabinols, a threshold that accommodates non-intoxicating full-spectrum hemp-derived CBD products. This framework supports patient-provider discussions around eligible hemp products, reinforcing science-driven policymaking that prioritizes consumer safety and product quality.

  • The new CMS guidance was released on March 20, 2026.

The players

Charlotte's Web Holdings, Inc.

A botanical wellness innovation company and the market leader in cannabidiol (CBD) hemp extract wellness products, headquartered in Louisville, Colorado.

Centers for Medicare & Medicaid Services (CMS)

The federal agency that administers the Medicare program and works in partnership with state governments to administer Medicaid, the State Children's Health Insurance Program (SCHIP), and health insurance portability standards.

Bill Morachnick

The CEO of Charlotte's Web.

Got photos? Submit your photos here. ›

What they’re saying

“We are grateful for CMS's thoughtful approach in expanding access and creating space for responsible, evidence‑based hemp wellness conversations in clinical settings.”

— Bill Morachnick, CEO of Charlotte's Web

What’s next

Charlotte's Web will continue to champion policy solutions that uphold safety, transparency, and the availability of trusted full‑spectrum hemp products.

The takeaway

This CMS guidance represents a significant step forward in advancing access to eligible full-spectrum hemp products, aligning with Charlotte's Web's mission to provide safe, high-quality, science-backed hemp options for consumers and support sensible legislation that protects patients and strengthens the integrity of the hemp industry.